DEAN L. MANN, M.D.; NEIL I. GALLAGHER, M.D.; ROBERT M. DONATI, M.D.
Erythrocytosis as an unusual complication of cancer has been documented in an increasing number of reports. The prevalence and the pathogenesis of this association have recently been reviewed by Lange and Pavlovic-Kentera (1). In selected instances an apparent direct causal relationship between uterine myoma, cerebellar hemangioblastoma, renal carcinoma, renal adenoma, or pheochromocytoma and erythrocytosis has been suggested because of remission of the erythrocytosis after surgical extirpation or radiologic obliteration of the tumor. Moreover, elevation of plasma erythropoietin levels has been described in patients with erythrocytosis and renal carcinoma (2), hepatic carcinoma (2-4), cerebellar hemangioblastoma (5, 6), or pheochromocytoma (7), and
MANN DL, GALLAGHER NI, DONATI RM. Erythrocytosis and Primary Aldosteronism. Ann Intern Med. ;66:335–340. doi: 10.7326/0003-4819-66-2-335
Download citation file:
Published: Ann Intern Med. 1967;66(2):335-340.
Adrenal Disorders, Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use